JAK2 and atypical chronic myeloid leukemia, BCR-ABL1 negative: Other mutations shown in >20% of aCML involve N/K-RAS, SRSF2, and TET2, while less frequent (<10%) mutations include CBL, JAK2, and EZH2 [2,7,19,20].